SeaStar Medical (ICU)
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammat...
- Open
- 3.320
- High
- 3.500
- Low
- 3.271
- Prev. Close
- 3.340
- Volume
- 68.76K
- Turnover
- 232.78K
- Avg Price
- 3.385
- Bid/Ask Ratio
- --
- Amplitude
- 6.86%
- 52wk High
- 12.500
- Volume Ratio
- 1.08
- Turnover Ratio
- 1.74%
SeaStar Medical Analyst Rating
View moreForecast & Rating
Aug 17, 2026Price forecast
$10.00198.51%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Aug 19 at 03:22 PM
SeaStar Medical CFO Michael Messinger acquires 750 common shares worth $2,452.5
- TradingKey · Aug 14 at 03:24 AM
SeaStar Medical (ICU) Q2 2026 Earnings Call: Revenue Up 82%, AKI Trial Advances
- Motley Fool · Aug 12 at 08:26 PM
SeaStar Medical (ICU) Q2 2026 Earnings Call Transcript
- Quartr · Aug 12 at 05:04 PM
ICU: QUELIMMUNE revenue surged 82% as adoption doubled, and adult AKI trial enrollment advanced on schedule
- Earnings Watch · Aug 12 at 03:30 PM
SeaStar Medical | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 615 K
- PUBT · Aug 6 at 07:35 AM
SeaStar Medical to report second-quarter results after market close, host webcast call
